NURS6521: Week 9 – Discussion 

Discussion: Women’s and Men’s Health,
Infectious Disease, and Hematologic

Disorders

● As an advanced practice nurse, you will likely experience patient encounters with
complex comorbidities. For example, consider a female patient who is pregnant
who also presents with hypertension, diabetes, and has a recent tuberculosis
infection. How might the underlying pathophysiology of these conditions affect
the pharmacotherapeutics you might recommend to help address your patient’s
health needs? What education strategies might you recommend for ensuring
positive patient health outcomes?
For this Discussion, you will be assigned a patient case study and will consider
how to address the patient’s current drug therapy plans. You will then suggest
recommendations on how to revise these drug therapy plans to ensure effective,
safe, and quality patient care for positive patient health outcomes.

●
● Photo Credit: Getty Images
To Prepare
● Review the Resources for this module and reflect on the different health needs
and body systems presented.
● Your Instructor will assign you a complex case study to focus on for this
Discussion.
● Consider how you will practice critical decision making for prescribing appropriate
drugs and treatment to address the complex patient health needs in the patient
case study you selected.
By Day 3 of Week 9
Post a brief description of your patient’s health needs from the patient case study you
assigned. Be specific. Then, explain the type of treatment regimen you would
recommend for treating your patient, including the choice or pharmacotherapeutics you
would recommend and explain why. Be sure to justify your response. Explain a patient
education strategy you might recommend for assisting your patient with the
management of their health needs. Be specific and provide examples.

Learning Resources

Required Readings (click to expand/reduce)
Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced
practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
● Chapter 46, “Anticoagulant and Antiplatelet Drugs” (pp. 364–371)
● Chapter 47, “Drugs for Deficiency Anemias” (pp. 389–396)
● Chapter 50, “Estrogens and Progestins: Basic Pharmacology and
Noncontraceptive Applications” (pp. 425–436)
● Chapter 51, “Birth Control” (pp. 437–446)
● Chapter 52, “Androgens” (pp. 447–453)
● Chapter 53, “Male Sexual Dysfunction and Benign Prostatic Hyperplasia” (pp.
454–466)
● Chapter 70, “Basic Principles of Antimicrobial Therapy” (pp. 651–661)
● Chapter 71, “Drugs That Weaken the Bacterial Cell Wall I: Penicillins” (pp.
662–668)
● Chapter 75, “Sulfonamides Antibiotics and Trimethoprim” (pp. 688–694)
● Chapter 76, “Drug Therapy of Urinary Tract Infections” (pp. 695–699)
● Chapter 78, “Miscellaneous Antibacterial Drugs” (pp. 711–714)
● Chapter 79, “Antifungal Agents” (pp. 715–722)
● Chapter 80, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 723–743)
● Chapter 82, “Drug Therapy of Sexually Transmitted Diseases” (pp. 763–770)
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., &
Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring

of hypogonadism in men. Aging Male, 18 (1), 5–15.
doi:10.3109/13685538.2015.1004049

This article presents recommendations on the diagnosis, treatment, and
monitoring of hypogonadism in men. Reflect on the concepts presented and
consider how this might impact your role as an advanced practice nurse in
treating men’s health disorders.

Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., …
Kendall, P. (2014). Expansion of HAART coverage is associated with sustained
decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment
as Prevention” experience in a Canadian setting. PLoS ONE, 9(2), e87872. Retrieved
from https://doi.org/10.1371/journal.pone.0087872

This study examines HAART therapy and its sustainability and profound population-
level decrease in morbidity, mortality, and HIV transmission.
Roberts, H., & Hickey, M. (2016). Managing the menopause: An update. Maturitas,
86 (2016), 53–58. .https://doi.org/10.1016/j.maturitas.2016.01.007

This article provides an update on treatments on Vasomotor symptoms
(VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance,
sexual dysfunction, and mood disturbance that are common during the
menopause transition.

Agency for Healthcare Research and Quality. (2014). Guide to clinical preventive
services, 2014: Section 2. Recommendations for adults. Retrieved from
http://www.ahrq.gov/professionals/clinicians-providers/guidelines-
recommendations/guide/section2.html

This website lists various preventive services available for men and women and
provides information about available screenings, tests, preventive medication, and
counseling.
Required Media (click to expand/reduce)

Laureate Education (Producer). (2019h). Pathopharmacology: Pharmacology and
immunological disorders: Improvements in medications and drug administration [Video
file]. Baltimore, MD: Author.
Note: The approximate length of this media piece is 8 minutes.
Nurse Manager, Bette Nunn discusses how technology has improved the practice of
administering drugs and created new and improved drug therapies. The importance of
using technology as well as a patient’s knowledge of their own drug history is also
discussed.

Accessible player –Downloads–Download Video w/CCDownload AudioDownload
Transcript
Speed Pharmacology. (2018). Pharmacology – Antibiotics – Cell wall & membrane
inhibitors (Made Easy) [Video].
https://www.youtube.com/watch?v=mMk6VWVpRpo&t=504s
Note: This media program is approximately 16 minutes.
Speed Pharmacology. (2018). Pharmacology – Antibiotics – DNA, RNA, folic acid,
protein synthesis inhibitors (Made Easy) [Video].
https://www.youtube.com/watch?v=5HQmvQJWzNY&t=32s